Resilience is the Key Differentiator in Today’s Chemicals Landscape
Connecting cost-advantaged production, technology leadership, access to global markets, and disciplined capital allocation to upgrade portfolio.
Resilience
Resilience Will Close 6 of its 10 Plants
Resilience recently shared that capacity expansions have exceeded current industry demand. As a result, Resilience has begun consolidating its operations and streamlining its business strategy.
Resilience and Mubadala in Biopharma Venture
US biopharma manufacturing and technology company National Resilience has entered into an agreement with Abu Dhabi investor Mubadala Investment Company to build a manufacturing plant in the United Arab Emirate’s biggest city. This will be the first GMP biopharma facility in the UAE.
Chemistry and the „Next Normal”
Numerous crises such as climate change, energy shortages, raw material shortages, war in Ukraine and the consequences of the pandemic are putting value chains worldwide to the test.
AstraZeneca Boosts Cancer Portfolio with Neogene Buy
AstraZeneca has agreed to acquire Neogene Therapeutics, a clinical-stage biotechnology company focused on the discovery, development and manufacture of next-generation T-cell receptor therapies (TCR-Ts) – a promising and novel cell therapy approach to target cancer.
